Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

49-60 of 1008 results
Page 5 of 84
Key Publications December 1, 2022

Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes.

Nat Med. 2022;28:1693-1699

Pickersgill SJ, Msemburi WT, Cobb L, Ide N, Moran AE, Su Y, Xu X, Watkins DA
Cardiovascular Disease Hypertension Prevention
Key Publications November 23, 2022

Hypertension control among us adults, 2009 to 2012 through 2017 to 2020, and the impact of COVID-19.

Hypertension. 2022;79:1981-1983

Egan BM
Epidemiology Hypertension Respiratory Diseases
Key Publications November 23, 2022

Blood pressure control among US adults, 2009 to 2012 through 2017 to 2020.

Hypertension. 2022;79:1971-1980

Muntner P, Miles MA, Jaeger BC, Hannon Iii L, Hardy ST, Ostchega Y, Wozniak G, Schwartz JE
Cardiovascular Disease Epidemiology Hypertension
Key Publications November 23, 2022

Uric acid and hypertension: a review of evidence and future perspectives for the management of cardiovascular risk.

Hypertension. 2022;79:1927-1936

Borghi C, Agnoletti D, Cicero AFG, Lurbe E, Virdis A
Cardiovascular Disease Hypertension Prevention
Key Publications November 16, 2022

What is the optimal anthropometric index/ratio associated with two key measures of cardio-metabolic risk associated with hypertension and diabetes?

Int J Obes (Lond). 2022;46:1304-1310

Nevill AM, Lang JJ, Tomkinson GR
Abdominal Obesity/Body Fat Distribution Diabetes Hypertension
Key Publications October 19, 2022

Time to clinical benefit of intensive blood pressure lowering in patients 60 years and older with hypertension: a secondary analysis of randomized clinical trials.

JAMA Intern Med. 2022;182:660-667

Chen T, Shao F, Chen K, Wang Y, Wu Z, Wang Y, Gao Y, Cornelius V, Li C, Jiang Z
Age Clinical Trials Hypertension
Key Publications October 18, 2022

Omega-3 polyunsaturated fatty acids intake and blood pressure: a dose-response meta-analysis of randomized controlled trials.

J Am Heart Assoc. 2022;11:e025071

Zhang X, Ritonja JA, Zhou N, Chen BE, Li X
Clinical Trials Hypertension Nutrition
Key Publications October 18, 2022

Blood pressure-lowering effects of omega-3 polyunsaturated fatty acids: are these the missing link to explain the relationship between omega-3 polyunsaturated fatty acids and cardiovascular disease?

J Am Heart Assoc. 2022;11:e026258

George M, Gupta A
Cardiovascular Disease Hypertension Nutrition
Key Publications October 17, 2022

Longitudinal associations between fat-derived dietary patterns and early markers of cardiovascular disease risk in the UK Biobank study.

J Am Heart Assoc. 2022;11:e024069

Brayner B, Keske MA, Kaur G, Islam SMS, Perez-Cornago A, Piernas C, Livingstone KM
Cardiovascular Disease Hypertension Nutrition
Key Publications October 14, 2022

Hypertension, arterial stiffness, and diabetes: a prospective cohort study.

Hypertension. 2022;79:1487-1496

Tian X, Zuo Y, Chen S, Zhang Y, Zhang X, Xu Q, Wu S, Wang A
Clinical Cardiology Diabetes Hypertension
Key Publications October 13, 2022

Jeremiah Stamler, MD (1919-2022).

Hypertension. 2022;79:e111-e112

Greenland P, Van Horn LV
Cardiovascular Disease Hypertension Prevention
Key Publications September 21, 2022

Ambient air pollution and cardiovascular diseases: An umbrella review of systematic reviews and meta-analyses.

J Intern Med. 2022;291:779-800

de Bont J, Jaganathan S, Dahlquist M, Persson Å, Stafoggia M, Ljungman P
Cardiovascular Disease Epidemiology Hypertension
of 84